Boogie,I did read the report.Where in my previous post did I state GCN was on moving trains ?My response was to your previous post regarding COST - notwhat is occuring.Please try to stay on track - pardon the pun.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status